Skip to main content
FinSpry Logo
FinSpry
QGEN logo
QGEN
(NYSE)
Qiagen N.V.
$42.95-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Qiagen (QGEN) Stock Price & Financial Analysis

Qiagen Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$42.77 - $43.73
52-Week High$57.82
52-Week Low$32.53
Open$43.55
Volume3.67M
Average Volume (3M)2.84M
Market Cap8.97B
Shares Outstanding208.94M
P/E Ratio (TTM)21.98
Forward P/E10.93
Price to Sales (P/S)4.21
Price to Book (P/B)2.65
EV/EBITDA14.16
Revenue (TTM)2.10B
Net Income (TTM)402.17M
Free Cash Flow (TTM)410.54M
EPS (TTM)$1.93
Profit Margin19.16%
Operating Margin25.91%
Return on Equity (ROE)12.07%
Debt to Equity0.49
50-Day MA$39.49
200-Day MA$43.60
52-Week Change-11.95%
Annual Dividend$4.70
Dividend Yield11.11%
Payout Ratio200.00%
Last Dividend Ex-DateJul 7, 2026

Frequently Asked Questions About Qiagen

What is the current stock price for QGEN?

As of the latest trading session, QGEN stock trades at $42.95. The 52-week range is $32.53–$57.82, with a day range of $42.77–$43.73.

What is the P/E ratio for QGEN?

Qiagen's trailing P/E ratio is 22.0, meaning investors pay $22.0 for every $1 of annual earnings. The forward P/E is 10.9, reflecting analyst expectations for future earnings. Qiagen operates in the Healthcare sector.

Does QGEN pay dividends?

Yes, Qiagen pays a 11.11% annual dividend yield ($4.70 per share). The payout ratio is 200.0%. The last ex-dividend date was 2026-07-07.

What do analysts recommend for QGEN?

Based on 10 analysts, the consensus for QGEN is Buy.

What is the market cap of QGEN?

Qiagen's market capitalization is $8.97B, classifying it as a mid-cap company. Qiagen operates in the Healthcare sector within the Diagnostics & Research industry.